Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2000
09/06/2000EP1032427A2 Conjugates of cytokines and drugs or genes for treating proliferating cells
09/06/2000EP1032426A1 Therapeutic agents
09/06/2000EP1032425A1 Gellan gum tablet coating
09/06/2000EP1032422A1 Linear antigen supporting units
09/06/2000EP1032409A1 Herbal extract composition and method with immune-boosting capability
09/06/2000EP1032405A1 Antimutagenic compositions for treatment and prevention of photodamage to skin
09/06/2000EP1032399A1 Progestin therapy with controlled bleeding
09/06/2000EP1032391A1 Spheroids containing tiagabine, preparation process and pharmaceutical compositions
09/06/2000EP1032390A1 Anaesthetic formulation
09/06/2000EP1032381A1 Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
09/06/2000EP1032379A1 Composition with azelaic acid
09/06/2000EP1032378A1 Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases
09/06/2000EP1032373A1 Drug delivery systems utilizing liquid crystal structures
09/06/2000EP1032371A1 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
09/06/2000EP1032370A1 Porous hydroxyapatite particles as carriers for drug substances
09/06/2000EP1032368A1 Iontophoretic devices comprising piperidin derivatives
09/06/2000EP1032357A1 Use of fluorinated solvents for the formulation of hair lotions
09/06/2000EP0817612B1 Transparent rapid-release preparations of non-steroid analgesics
09/06/2000EP0792149B1 Oral compositions containing ondansetron
09/06/2000EP0631502B1 Lymphocyte activity regulation by hla peptides
09/06/2000EP0587858B1 Protein formulation comprising growth hormone
09/06/2000CN1265690A Process for preparing porous polyolefin particles
09/06/2000CN1265634A Improved method for preparing low-concentration polyaluminosilicate microgels
09/06/2000CN1265597A Composition comprising propolis and at least an essential oil
09/06/2000CN1265595A Pharmaceutical composition containing vitamin D and calcium, their preparation and therapeutic use
09/06/2000CN1265593A Novel process for manufacturing paroxetine solid dispersions
09/06/2000CN1265587A Fast-acting analgesic
09/06/2000CN1265584A Ascorbic acid-based formulation with improved colour stability
09/06/2000CN1265327A Making process of subunit antigen vaccine cream
09/06/2000CN1056084C Immunotoxins directed against CD33 related surface antigens
09/06/2000CN1056083C Method and compositions for treatment and repair of defects or lesions in cartilage
09/06/2000CN1056058C Prep. of pharmaceutical formulation
09/06/2000CN1056057C Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administraion
09/05/2000US6114509 Polypeptide with reduced allergenicity
09/05/2000US6114394 Protecting mammalian cells from harmful cellular effects caused by exposure to ionizing radiation
09/05/2000US6114388 Monofunctional and/or polyfunctional polylysine conjuages
09/05/2000US6114348 Method of treating warts using tazarotene
09/05/2000US6114313 Mixture of nucleotide, mannitol and adjuvants
09/05/2000US6113948 Microparticles and their use in wound therapy
09/05/2000US6113947 Controlled release microencapsulated NGF formulation
09/05/2000US6113946 Self-assembling polynucleotide delivery system comprising dendrimer polycations
09/05/2000US6113943 Active substance with hydrolyzed lactic acid polymer
09/05/2000US6113942 Pharmaceutical composition for piperidinoalkanol compounds
09/05/2000US6113937 Sustained release sufentanil compositions
09/05/2000US6113919 Preparations comprising a fluorocarbon or a highly fluorinated compound and a lipophilic/fluorophilic compound and their uses
09/05/2000US6113911 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method
09/05/2000US6113906 Water-soluble non-antigenic polymer linkable to biologically active material
09/05/2000US6113903 Antidiabetic agents
09/05/2000US6113894 Treatment of blepharitis of the cornea of eyes, applying compositiion with viscosity adjusting agent, preservatives, buffers, nonionic surfactants and lipids
09/05/2000US6113882 Cosmetic compositions comprising copolymers with a flexible backbone which are grafted with hydrophobic and rigid macromonomers
09/05/2000US6113629 Hydrogel for the therapeutic treatment of aneurysms
09/05/2000CA2299952A1 Improved pellet formulations
09/05/2000CA2202520C Lyophilized pharmaceutical preparations capable of providing aqueous drug composition having property of reversible thermosetting gelation
09/05/2000CA2083683C Stable formulation of analapril salt, a process for the preparation thereof and the use thereof
09/05/2000CA2006596C Chemically-modified g-csf
08/2000
08/31/2000WO2000050618A1 Virus vector
08/31/2000WO2000050460A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
08/31/2000WO2000050456A2 Covalently bridged insulin dimers
08/31/2000WO2000050386A1 Compounds and compositions for delivering active agents
08/31/2000WO2000050090A2 Dry acid-chitosan complexes
08/31/2000WO2000050089A2 Regulation of the stability of recombinant proteins and antiboodies
08/31/2000WO2000050088A2 Biotinylated-chemokine antibody complexes
08/31/2000WO2000050087A1 Glycoconjugates obtained from candida utilis cells and ricinus communis seeds
08/31/2000WO2000050086A1 Molecules for the treatment and diagnosis of tumors
08/31/2000WO2000050085A2 Oil-in-water emulsion for the use as medicament or for producing a medicament
08/31/2000WO2000050083A1 Enteral sorbefacients
08/31/2000WO2000050077A1 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d
08/31/2000WO2000050059A1 Taxane derivatives for targeted therapy of cancer
08/31/2000WO2000050058A1 Cerebrospinal and vascular pharmaceutical composition and process for preparing the same
08/31/2000WO2000050050A1 Multiparticulate formulation
08/31/2000WO2000050046A1 Stabilized oral pharmaceutical composition containing iodide and iodate and method
08/31/2000WO2000050041A1 Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna-4,15-dien-20-yn-3-one (org 30659) and lactose
08/31/2000WO2000050038A1 Pharmaceutical composition containing proton pump inhibitors
08/31/2000WO2000050035A2 Premixed formulation of piperacillin sodium and tazobactam sodium injection
08/31/2000WO2000050018A2 Pharmaceutical preparation containing dithranol
08/31/2000WO2000050012A1 Solid oral dosage form containing an enhancer
08/31/2000WO2000050008A2 Antibody fragment-targeted immunoliposomes for systemic gene delivery
08/31/2000WO2000050004A2 Surgical anesthesia delivery system
08/31/2000WO2000049993A2 Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
08/31/2000WO2000049991A2 Treatment of trauma
08/31/2000WO2000049990A2 The process for manufacturing topical ophthalmic preparations without systemic effects
08/31/2000WO2000027849A3 Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
08/31/2000WO2000027425A3 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders
08/31/2000WO2000025753A3 Controlled delivery of active agents
08/31/2000WO2000023055A9 Oral pulsed dose drug delivery system
08/31/2000WO2000018949A9 Delivery of phosphoinositide polyphosphates into cells
08/31/2000WO1999042086A9 Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent
08/31/2000DE19908766A1 New synthetic peptides from the Vpr protein of human immune deficiency virus, useful e.g. for therapy and diagnosis, have good solubility in water
08/31/2000DE19908487A1 Pharmazeutische Zubereitung enthaltend Dithranol Pharmaceutical composition containing dithranol
08/31/2000DE19908184A1 Verfahren zur Herstellung wässriger Dispersionen von Copolymerisaten aus hydrophilen und hydrophoben Monomeren sowie daraus erhältliche Copolymerisate und deren Anwendungen A process for the preparation of aqueous dispersions of copolymers of hydrophilic and hydrophobic monomers as well as copolymers obtainable therefrom and their applications
08/31/2000DE19908041A1 Kovalent verbrückte Insulindimere Covalently bridged insulin dimers
08/31/2000DE19858005A1 Synthetisches Nucleinsäure-Partikel Synthetic nucleic acid particles
08/31/2000CA2689696A1 Microemulsions with adsorbed macromolecules and microparticles
08/31/2000CA2371849A1 Biotinylated-chemokine antibody complexes
08/31/2000CA2366943A1 Dry acid-chitosan complexes
08/31/2000CA2366712A1 A means for the prophylactic and therapeutic treatment of streptococcal infections
08/31/2000CA2365026A1 Virus vector
08/31/2000CA2364849A1 Compounds and compositions for delivering active agents
08/31/2000CA2364780A1 Enteral sorbefacients
08/31/2000CA2363637A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
1 ... 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 ... 1712